REQUEST A DEMO
Total
USD $0.00
Search more companies

UAB Biomedikos Centras (Lithuania)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: UAB Biomedikos Centras Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

UAB Biomedikos Centras is an enterprise based in Lithuania. Its main office is in Vilnius. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was incorporated on October 31, 2018. 31 (2025) employees currently work for UAB Biomedikos Centras. From the latest financial highlights, UAB Biomedikos Centras reported a net sales revenue drop of 9.16% in 2024. The net profit margin of UAB Biomedikos Centras decreased by 2.98% in 2024.

Headquarters
Antakalnio g. 36
Vilnius; Vilnius county; Postal Code: LT-10305

Contact Details: Purchase the UAB Biomedikos Centras report to view the information.

Basic Information
Total Employees:
Purchase the UAB Biomedikos Centras report to view the information.
Registered Capital:
Purchase the UAB Biomedikos Centras report to view the information.
Financial Auditors:
Purchase the UAB Biomedikos Centras report to view the information.
Incorporation Date:
October 31, 2018
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after UAB Biomedikos Centras report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-9.16%
Total operating revenue
-9.16%
Net Profit (Loss) for the Period
-68.94%
Total Equity
14.5%
Net Profit Margin
-2.98%
Return on Equity (ROE)
-34.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?